Zim Laboratories logo

Zim Laboratories results

NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap

Last close ₹126.22down ₹5.90 (4.47%)BSE ₹126.60

Share price at the NSE close on 23 Oct 2026. Previous close ₹132.12.

52-week range of traded prices to 23 Oct 2026
₹59.31Low, 30 Mar 2026₹159.81High, 12 Oct 2026
Market cap
₹677 Cr1,933rd largest listed
P/E
183.2
P/B
2.3
Dividend yield
Nonein the last 12 months
ROE
1.3%
ROCE
1.8%
Debt to equity
0.42
Volume, NSE
1,16,71445.7% delivered

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Zim Laboratories annual results and balance sheet

Revenue
₹94 Cr+31.2% on a year ago · −10.5% on the quarter before
Operating profit
₹2.45 Cr−42.5% on a year ago · −65.9% on the quarter before
Net profit
−₹4.02 Cr
Earnings per share
−₹0.75
Operating margin
2.6%
Net margin
−4.3%

From revenue to net profit, ₹ crore

  1. Revenue94
  2. Materials and goods−39
  3. Employee costs−19
  4. Other expenses−33
  5. Operating profit2.5
  6. Depreciation−5.4
  7. Other income+1.0
  8. Finance costs−3.6
  9. Profit before tax−5.6
  10. Tax+1.6
  11. Net profit−4.0

Zim Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 2 NovDec 2021Q3Filed 31 JanMar 2022Q4Filed 25 MayJun 2022Q1Filed 28 JulSep 2022Q2Filed 25 NovDec 2022Q3Filed 7 FebMar 2023Q4Filed 7 JunJun 2023Q1Filed 14 AugSep 2023Q2Filed 17 NovDec 2023Q3Filed 6 FebMar 2024Q4Filed 14 MayJun 2024Q1Filed 22 AugSep 2024Q2Filed 9 NovDec 2024Q3Filed 10 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 7 AugSep 2025Q2Filed 12 NovDec 2025Q3Filed 11 FebMar 2026Q4Filed 19 MayJun 2026Q1Filed 6 Aug
Revenue from operations77871059399101105678696118829296109728910910594
67769082878890637785102748385946783969892
Materials and goods bought3642504652515031404456364241483040494739
Employee costs99111212121313131315151514161516161719
Other expenses2225292423252719242731232529302327323433
Operating profit before depreciation101115111213155912168101215461372
Operating margin13.3%12.3%14.0%12.1%12.3%13.0%14.7%7.2%10.9%12.0%13.3%9.8%10.3%12.0%13.4%5.9%6.5%11.8%6.8%2.6%
Depreciation and amortisation44444454444555555555
Other income11221211112112212261
Finance costs32111212122333333334
One-off items00000000000000000000
Profit before tax4611781010057111368−2065−6
124233301230123−1021−2
Tax rate22.4%29.6%34.7%31.1%31.5%33.9%27.2%−22.2%23.8%31.8%26.5%27.2%19.6%29.9%39.8%––27.3%24.3%–
347557704581245−2044−4
Other comprehensive income000010−10000000000100
Total comprehensive income348667704581344−1054−4
Net margin4.2%4.7%6.7%5.6%5.5%6.5%6.9%0.3%4.8%5.0%6.9%1.1%2.6%4.2%4.5%−2.6%−0.5%4.0%3.6%−4.3%
Earnings per share₹0.67₹0.84₹1.44₹1.06₹1.12₹1.35₹1.48₹0.05₹0.85₹0.98₹1.66₹0.18₹0.49₹0.82₹1.01−₹0.38−₹0.09₹0.90₹0.76−₹0.75
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each

16 earlier filings